BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3787494)

  • 1. [Level of circulating immune complexes in lymphogranulomatosis patients as a criterion of the status and prognosis of the disease].
    Savina NP
    Ter Arkh; 1986; 58(9):60-4. PubMed ID: 3787494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circulating immune complexes in malignant tumors].
    Savina NP
    Sov Med; 1989; (8):8-10. PubMed ID: 2814673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobin levels in patients with Hodgkin's disease.
    Dienstbier Z; Koprivová H; Bechynĕ M; Zizkovský V; Foltýnová V; Rezný Z; Jirkovský J
    Neoplasma; 1978; 25(6):723-31. PubMed ID: 752117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes.
    Kauffmann RH; de Rooy-Dijk HH; Klein F; Lafeber GJ; Cats A; van Es LA
    Clin Exp Immunol; 1983 Oct; 54(1):203-12. PubMed ID: 6311469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3-year results of the combined treatment of stage I and II lymphogranulomatosis patients].
    Baĭsogolov GD; Shakhtarina SV
    Med Radiol (Mosk); 1984 Apr; 29(4):46-50. PubMed ID: 6546966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of serum innumoglobulin levels in Hodgkin's disease.
    Alsabti EA; Shaheen A
    Neoplasma; 1979; 26(3):329-33. PubMed ID: 530336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating and tumor tissue-bound immune complexes in patients with breast cancer].
    Dorosevich AE
    Arkh Patol; 1983; 45(7):30-6. PubMed ID: 6354144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Appearance of circulating immune complexes in patients with Hodgkin's disease and the etiology of this disease].
    Dziewulska-Bokiniec A; Sztaba-Kania M
    Wiad Lek; 1992 Oct; 45(19-20):740-3. PubMed ID: 1296377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of splenectomy on the levels of circulating immune complexes (CIC) in Hodgkin's disease (HD).
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1987; 34(1):89-93. PubMed ID: 3561608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunoregulatory lymphocytes and circulating immune complexes in gastric cancer].
    Moroz TD
    Eksp Onkol; 1987; 9(4):56-9. PubMed ID: 3500034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic results in lymphogranulomatosis and their relationship to immunological reactivity].
    Dienstbier Z; Foltýnová V; Hlavatý V; Kopricová H; Masopust J
    Vopr Onkol; 1981; 27(4):22-6. PubMed ID: 7233870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoglobulin levels in patients with Hodgkin's disease: relation to disease activity and clinical stage.
    Douer D; Pick AI; Kessler E; Vana D; Kenan Z
    Clin Oncol; 1978 Sep; 4(3):209-13. PubMed ID: 750123
    [No Abstract]   [Full Text] [Related]  

  • 13. [Circulating immune complexes in the serum in Hodgkin's disease].
    Nikolić V; Zivanović L; Banićević B; Milosević-Jovcić N
    Bilt Hematol Transfuz; 1980; 8(1):19-27. PubMed ID: 7337679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long term effects of splenectomy on the immune-status of Hodgkin's disease patients depending on the modality of treatment (author's transl)].
    Schaadt M; Diehl V; Kalden JR; Schmidt N; Laskewitz E
    Med Klin; 1978 Oct; 73(40):1381-8. PubMed ID: 309061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of the radiation therapy of lymphogranulomatosis according to immunoreactivity data].
    Khvorostenko MI
    Med Radiol (Mosk); 1980 Jan; 25(1):37-41. PubMed ID: 7354712
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunodeficiencies in Hodgkin's Disease. Part II: B cell immunity, complement systems and phagocytic cell systems.
    Gupta S
    Clin Bull; 1981; 11(3):110-9. PubMed ID: 7039866
    [No Abstract]   [Full Text] [Related]  

  • 17. [Circulating immune complexes and neutrophilic phagocytic function in patients with idiopathic autoimmune thrombocytopenic purpura].
    Tishchenko LM; Volobueva ZV
    Vrach Delo; 1991 May; (5):80-3. PubMed ID: 1866927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
    Tomasević Z; Jelić S
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects and therapy of stage III Hodgkin's disease (author's transl)].
    Weh HJ; Andrieu JM
    MMW Munch Med Wochenschr; 1980 Jun; 122(25):932-4. PubMed ID: 6772941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The bone marrow in Hodgkin's disease following radiotherapy and splenectomy].
    Baĭsogolov GD; Pavlov VV; Bogatyreva TI; Khait SE; Kuz'mina EG
    Med Radiol (Mosk); 1987 May; 32(5):3-7. PubMed ID: 3586920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.